Phase
Condition
Peripheral Arterial Occlusive Disease
Circulation Disorders
Vascular Diseases
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subject is at least 18 years of age
Subject or authorized representative has signed a written Informed Consent
Subject is willing to comply with the protocol requirements
Rutherford classification 4-6
Planned intervention of the native infrapopliteal arteries using balloonangioplasty, atherectomy, and endovascular procedures.
Reference vessel diameter for intended location of the distal tip funnel deploymentfor the Protexus catheter is ≥3.5mm and ≤6.0mm by visual estimate
Inflow arteries have ≤30% stenosis. Inflow arteries can be treated at the time ofthe study procedure to achieve ≤30% stenosis
Exclusion
Exclusion Criteria:
Prior intervention within 30 days of treatment in the planned deployment site forthe Protexus catheter
Presence of a stent in the planned deployment site for the Protexus catheter
Has perforation, dissection, or other injury of the access vessel or Protexuscatheter deployment site requiring additional stenting or surgical interventionbefore enrollment
History of bleeding diathesis or coagulopathy and unable to receive standardanticoagulation during the index procedure
Acute limb ischemia defined as onset of symptoms within two weeks of the plannedintervention
Inflow arteries have >30% stenosis after treatment at the time of the studyprocedure
Pregnant female subject or subject that has a positive pregnancy test within theprevious 7 days
Known hypersensitivity or allergy to nitinol
Target blood vessels are infected, have extreme tortuosity, or are occluded withcalcified material